Patients Taking AUSTEDO XR® (deutetrabenazine) extended-release tablets Reported Symptom Improvement and High SatisfactionPARSIPPANY, N.J. and TEL AVIV, Israel, Sept. 20, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the presentation of data from a real-world survey of patients taking AUSTEDO XR® (deutetrabenazine) extended-release tablets. Patients taking AUSTEDO XR reported increased social and emotional well-being as a result of movement reduction, and high overall satisfaction with AUSTEDO XR. The data were presented at the 2025 Psych Congress Annual Meeting, taking place from September 17 – 21, 2025 in San Diego, California.
New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-'749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS ObservedPARSIPPANY, N.J., and TEL AVIV, Israel, Sept. 20, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the presentation of 10 posters from its innovative schizophrenia medicines portfolio, including long-term safety data from the completed SOLARIS Phase 3 trial showing no incidence of post-injection delirium/sedation syndrome (PDSS) in study participants taking olanzapine LAI (TEV-'749), a once-monthly, long-acting injectable (LAI) subcutaneous formulation of olanzapine.1 New data evaluating UZEDY®, an extended-release injectable suspension of risperidone for subcutaneous use every one or two months for the treatment of schizophrenia in adults, found that it was associated with a shorter length of hospitalization compared to a once-monthly intramuscular injection of Invega Sustenna®.1 No comparisons can be made regarding efficacy, safety, or any other clinical outcomes as this was not studied. The data were presented at the 2025 Psych Congress Annual Meeting, taking place from September 17–21, 2025, in San Diego, California.
Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHRNEW YORK, Sept. 20, 2025 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher Corporation (
NYSE: DHR).
Wiingy Report: Trump’s $100,000 H1B Visa Fee Opens Over Half a Million Tech Jobs to AmericansDOVER, United Kingdom, Sept. 20, 2025 (GLOBE NEWSWIRE) -- A new report by Wiingy, "583,000 Tech Jobs Now Open for Americans: How the $100K H1B Fee Changes Everything" states that a federal policy introducing a $100,000 H1B visa application fee will create over 583,000 new tech jobs for U.S. workers by 2029.
C4 Therapeutics Presents Cemsidomide Phase 1 Multiple Myeloma Data Supporting Potential Best-in-Class Profile at the International Myeloma Society Annual MeetingCemsidomide in Combination With Dexamethasone Achieved a 50% Overall Response Rate (ORR) at the Highest Dose Level (100 µg) and a 40% ORR at the 75 µg Dose Level in a Heavily Pre-Treated Relapsed/Refractory Multiple Myeloma Patient Population
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MLNK, WOW, NWE on Behalf of ShareholdersNEW YORK, Sept. 20, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VMEO, TGNA, GTLS on Behalf of ShareholdersNEW YORK, Sept. 20, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PGRE, ETNB, STAA on Behalf of ShareholdersNEW YORK, Sept. 20, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
CGTN: Nurturing 'she power': Peng Liyuan calls to empower women with science educationCGTN published an article on the 2025 UNESCO Prize for Girls' and Women's Education ceremony, which coincided with the 10th anniversary of the Prize, held in Beijing on Friday. The article explores the critical role of science education in empowering future generations of women with the know-how and innovative capacity needed in an AI-driven era.
OTTAWA BANCORP, INC. ANNOUNCES COMPLETION OF STOCK REPURCHASE PROGRAMOTTAWA, Ill., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Ottawa Bancorp, Inc. (OTCQX: OTTW), the “Company”, the holding company for OSB Community Bank, announced today that the Company has completed its previously announced stock repurchase program. Under the program, the Company repurchased 120,996 shares of its outstanding common stock at an average price of $15.01 per share.
Chapman University Partners with Marymount Education Foundation to Expand Access and Support for StudentsA new collaboration will welcome Marymount Scholars to Chapman, pairing financial aid with mentorship, community, and holistic student support
Faraday Future Announces Strategic $41 Million Investment in Qualigen Therapeutics, Inc. (NASDAQ: QLGN) for Crypto Business Through PIPE TransactionLOS ANGELES and CARLSBAD, Calif., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Faraday Future Intelligent Electric Inc. (
NASDAQ: FFAI) (“Faraday Future”, “FF” or “Company”), a California-based global shared intelligent electric mobility ecosystem company, and Qualigen Therapeutics, Inc. (
NASDAQ: QLGN) ("QLGN"), jointly announced that they have entered into a securities purchase agreement (the “Agreement”) for a private investment in public equity (PIPE) in QLGN’s common stock and preferred stock, and will start a crypto and web3-related business.
National Healthcare Properties Announces Preferred Stock DividendsNEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) -- National Healthcare Properties, Inc. (Nasdaq: NHPAP / NHPBP) (“NHP”) announced today that it declared quarterly dividends on its outstanding preferred stock. Specifically, NHP declared a dividend of $0.4609375 per share on its 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock payable on October 15, 2025 to holders of record at the close of business on October 3, 2025. In addition, NHP declared a dividend of $0.4453125 per share on its 7.125% Series B Cumulative Redeemable Perpetual Preferred Stock payable on October 15, 2025 to holders of record at the close of business on October 3, 2025.
MediaAlpha, Inc. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors (MAX)NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against MediaAlpha, Inc. (“MediaAlpha” or the “Company”) (
NYSE:MAX). The investigation concerns whether the Company may have violated federal securities laws or engaged in other unlawful business practices.
RedCloud to Present AI-Native Vision to Digitize and Transform Global TradeLONDON, Sept. 19, 2025 (GLOBE NEWSWIRE) -- RedCloud Holdings plc (Nasdaq: RCT) (“RedCloud” or the “Company”) the technology company behind the RedAI trading platform used by Fast Moving Consumer Goods (FMCG) Manufacturers, Distributors and Retailers, today announced that Justin Floyd, CEO and Co-Founder will be speaking at the 3rd Annual Roth AI Summit 2025 on September 24.
Revive Therapeutics Announces Closing of Second Tranche of Private PlacementTORONTO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company dedicated to developing innovative therapeutics for critical medical needs, announces that it has closed a second tranche of its previously announced private placement (see press release of September 5, 2025) by issuing 4,352,381 units, at a price of $0.021 per unit, for gross proceeds to Revive of $91,400.
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)SAN CARLOS, Calif., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (
NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (“TIL”) therapies for patients with cancer, today announced that on September 18, 2025 (the “Date of Grant”), the Company approved the grant of inducement stock options covering an aggregate of 22,810 shares of Iovance’s common stock to two new, non-executive employees.
Children's Advertising Review Unit Recommends MrBeastYouTube, LLC and Feastables Improve Ad Disclosures, Product Claims, and Data Collection PracticesFollowing its marketplace monitoring of children’s advertising, BBB National Programs’ Children’s Advertising Review Unit (CARU) recommended that MrBeastYouTube, LLC, and its affiliate Feastables, update their advertising and data collection practices for the MrBeast YouTube channel, Feastables’ Sweepstakes, and the Feastables website to comply with CARU’s Advertising Guidelines, CARU’s Privacy Guidelines, and the Children’s Online Privacy Protection Act (COPPA).
Wellchange Holdings Company Limited Announces $4 Million Private PlacementNEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Wellchange Holdings Company Limited (“WCT” or the “Company”) (Nasdaq: WCT) today announced that it has entered into a securities purchase agreement (the “Agreement”) on September 9, 2025 with certain investor for the purchase and sale of up to an aggregate of 100,000,000 Class A ordinary shares, par value of $0.00005 per share (the “Class A Ordinary Shares”) of the Company, at a purchase price of about $0.04 per share in a private placement (the “Offering”).
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NOVATO, Calif., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (
NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases, today reported the grant of 48,561 restricted stock units of the company’s common stock to 17 newly hired non-executive officers of the company. The awards were approved by the compensation committee of the company’s board of directors and granted under the Ultragenyx Employment Inducement Plan, with a grant date of September 16, 2025, as an inducement material to the new employees entering into employment with Ultragenyx in accordance with Nasdaq Listing Rule 5635(c)(4).
Royalty Pharma to Present at Bernstein’s 2nd Annual Healthcare ForumNEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in a fireside chat at Bernstein’s 2nd Annual Healthcare Forum on Tuesday, September 23, 2025 at 2:50 p.m. ET.
North Oaks Unveils $50 Million, 5-Story Specialty Clinic Expansion in HammondNew 5-Story Clinic Building Expands Specialty Care, Strengthens Regional Healthcare Infrastructure
GENFIT Announces Discontinuation of its VS-01 Program in ACLF: VS-01 Development Refocused on UCDLille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), September 19, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced its decision to discontinue its VS-01 program in ACLF (Acute-on-Chronic Liver Failure), and reprioritize the development of VS-01 on UCD (Urea Cycle Disorder).
Sun Communities Reports Inducement Equity Award for Incoming Chief Executive OfficerSouthfield, MI, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Sun Communities, Inc. (
NYSE: SUI) (the “Company”), a real estate investment trust (“REIT”) that owns and operates, or has an interest in, manufactured housing (“MH”) and recreational vehicle (“RV”) communities, today announced the granting of an equity award to incoming Chief Executive Officer Charles D. Young.
FLR Investor Notice: Robbins LLP Reminds Investors of the Class Action Lawsuit Against Fluor CorporationSAN DIEGO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Fluor Corporation (
NYSE: FLR) securities between February 28, 2025 and July 31, 2025. Fluor provides engineering, procurement, and construction (“EPC”), fabrication and modularization, and project management services worldwide.
CYTK Investor Alert: Robbins LLP Reminds Investors of the Class Action Lawsuit Against Cytokinetics, Inc.SAN DIEGO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Cytokinetics, Inc. (
NASDAQ: CYTK) securities between December 27, 2023 and May 6, 2025. Cytokinetics is a biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised.
Credit Acceptance Announces Extension of Revolving Secured Warehouse FacilitySouthfield, Michigan, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Credit Acceptance Corporation (Nasdaq: CACC) (referred to as the “Company”, “Credit Acceptance”, “we”, “our”, or “us”) announced today that we extended the date on which our $200.0 million revolving secured warehouse facility will cease to revolve from September 21, 2026 to September 19, 2028. The interest rate on borrowings under the facility has been decreased from the Secured Overnight Financing Rate (“SOFR”) plus 225 basis points to SOFR plus 185 basis points. There were no other material changes to the terms of the facility.
NewtekOne, Inc. to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025BOCA RATON, Fla., Sept. 19, 2025 (GLOBE NEWSWIRE) -- NewtekOne, Inc. (
NASDAQ: NEWT) today announced that it will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Fall 2025 Investor Conference, taking place virtually on Tuesday, September 30, 2025.
Hydreight Announces Annual General Meeting ResultsVANCOUVER, British Columbia, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV: NURS, OTC: HYDTF, FSE: SO6) (“Hydreight” or the “Company”), is pleased to announce that at the 2025 Annual General Meeting (“AGM”) virtually held on September 19, 2025, the Company’s shareholders voted in favour of all items of business. All director nominees were elected.
Michael S. Eisenga, CEO of First American Properties, Issues Statement on Labor Market and Economic RealitiesCOLUMBUS, Wis., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Michael S. Eisenga, CEO of First American Properties, today released the following statement regarding the growing economic concerns tied to the U.S. labor market and broader economic indicators:
Third-annual Black Thriving in America report dives deep into Black life experiencesWashington, D.C., Sept. 19, 2025 (GLOBE NEWSWIRE) -- A new report examines the wellbeing of Black Americans through decades of research and surveys. “Black Thriving in America: 2025” is a product of Thurgood Marshall College Fund’s (TMCF) Dr. N. Joyce Payne Research Center (Payne Center) partnership with the Gallup Center on Black Voices. The report officially releases on Tuesday, Sept. 23 at 1 p.m. at an exclusive event in the Great Hall of The Gallup Building.
Tevogen Commends HHS for Addressing Long COVID, Emphasizes TVGN 489’s Potential Impact for 20 Million AmericansWARREN, N.J., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today expressed its gratitude to the U.S. Department of Health and Human Services (HHS), Secretary Robert F. Kennedy, Jr., and the Trump Administration for convening two Long COVID roundtables focused on patient experiences and research.
IPX1031 Executive Craig Brown, Esq. Named President of the Federation of Exchange AccommodatorsBrown to advance the mission of protecting and promoting 1031 Exchanges and Qualified Intermediaries as he begins his Presidency
Copyleaks Wins Tech & Learning Awards of Excellence: Back to School 2025 for AI LogicCopyleaks’ AI Logic Recognized for Promoting Academic Integrity and Responsible AI Adoption
Service Coordination Inc.’s New Website Expands Access for People with DisabilitiesFrederick, MD, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Service Coordination Inc. (SCI), Maryland’s leading provider of case management services, has launched a new website designed to expand access, simplify navigation, and highlight the voices of people with disabilities and their families.
Transaction in Own SharesTransaction in Own Shares
HCM III Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing September 22, 2025Stamford, CT, Sept. 19, 2025 (GLOBE NEWSWIRE) -- HCM III Acquisition Corp. (
NASDAQ: HCMAU) (the “Company”) announced today that, commencing September 22, 2025, holders of the units sold in the Company’s initial public offering may elect to separately trade the Company’s Class A ordinary shares and warrants included in the units. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The Class A ordinary shares and warrants that are separated will trade on the Nasdaq under the symbols “HCMA” and “HCMAW,” respectively. Those units not separated will continue to trade on the Nasdaq under the symbol “HCMAU.”
Town & Country Living Launches Eponymous Collection of Fully Coordinated Home FurnishingsNEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Town & Country Living has been in the business of home since 1954, making products for the biggest retailers and brands domestically and across the globe. Known as the “brand behind the brands”, the company has grown over the years to a cross-category giant in the home furnishings industry designing and selling home textiles for every room of the home – from kitchen, to bath, living rooms, bedrooms rugs and décor for both indoors and outdoors.
LEADING EDGE MATERIALS REPORTS QUARTERLY RESULTS TO JULY 31, 2025LEADING EDGE MATERIALS REPORTS QUARTERLY RESULTS TO JULY 31, 2025
VFC ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against V.F. Corporation and Encourages Investors to Contact the FirmBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In V.F. Corporation (VFC) To Contact Him Directly To Discuss Their Options
Seneca Polytechnic launches its first-ever master’s degree – a program in AITORONTO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Seneca Polytechnic is now offering its first-ever master’s degree with the introduction of the new Master of Artificial Intelligence Design & Development program. Combining an innovative, industry-focused curriculum with hands-on, work-integrated learning, the program will prepare graduates for high-demand careers. The new program was announced on Seneca’s website on September 12, 2025.
Bragar Eagel & Squire, P.C. Reminds Investors of Tronox, Savara, Quantum, and Fly-E that Lawsuits Have Been Filed and Encourages Investors to Contact the FirmNEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Tronox Holdings plc (
NYSE:TROX), Savara Inc. (
NASDAQ:SVRA), Quantum Corporation (
NASDAQ:QMCO), and Fly-E Group, Inc. (
NASDAQ:FLYE). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
Bragar Eagel & Squire, P.C. Reminds Investors of Unicycive, Nutex, LifeMD, and Snap that Lawsuits Have Been Filed and Encourages Investors to Contact the FirmNEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Unicycive (
NASDAQ:UNCY), Nutex Health Inc. (
NASDAQ:NUTX), LifeMD, Inc. (
NASDAQ:LFMD), and Snap, Inc. (
NYSE:SNAP). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo NordiskFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Novo To Contact Him Directly To Discuss Their Options
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of V.F. CorporationFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In VFC To Contact Him Directly To Discuss Their Options
SupplyCore Awarded U.S. Army JPEO-CBRND Contract to Protect U.S. Military Against CBRN ThreatsThe contract supports efforts to ensure the safety and readiness of the U.S. Army in the face of chemical, biological, radiological, and nuclear challenges.
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of CTO Realty GrowthFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In CTO To Contact Him Directly To Discuss Their Options
Bragar Eagel & Squire, P.C. Reminds Investors of KinderCare, CTO Realty, PubMatic, and Charter Communications that Lawsuits Have Been Filed and Encourages Investors to Contact the FirmNEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of KinderCare Learning Companies, Inc. (
NYSE:KLC), CTO Realty Growth, Inc. (
NYSE:CTO), PubMatic, Inc. (
NASDAQ:PUBM), and Charter Communications, Inc. (
NASDAQ:CHTR). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
Bragar Eagel & Squire, P.C. Reminds Investors of Altimmune and SelectQuote that Lawsuits Have Been Filed and Encourages Investors to Contact the FirmNEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Altimmune, Inc. (
NASDAQ:ALT) and SelectQuote, Inc. (
NYSE:SLQT). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
NOVO ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Novo Nordisk A/S and Encourages Investors to Contact the FirmBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Novo (NVO) To Contact Him Directly To Discuss Their Options
LINEAGE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Lineage, Inc. and Encourages Investors to Contact the FirmBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Lineage (LINE) To Contact Him Directly To Discuss Their Options
FLYWIRE (FLYW) ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Flywire Corporation and Encourages Investors to Contact the FirmIf you purchased or acquired securities in Flywire between February 28, 2024 and February 25, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648.
